Literature DB >> 6895657

Human antibodies recognizing the envelope glycoprotein of the baboon endogenous virus BaEV are of heterophil origin.

D Wernicke, R Kurth.   

Abstract

Human sera were previously shown to possess antibodies capable of recognizing purified retrovirus envelope glycoproteins. In an extension of earlier studies we investigated sera from various groups of patients for an immune reaction against purified glycoprotein of the baboon endogenous virus BaEV. Reproducible demonstrations of oncovirus-like particles in human teratocarcinomas focused our main interest on sera from patients with testicular tumors. The specificity of the positive immune reaction of sera from these patients against BaEV gp 70 was analyzed in a competition RIAs with haptens and different cell lysates and experiments employing deglycosylated BaEV envelope antigen. From these experiments we conclude that the sera from teratocarcinoma patients contain naturally occurring, heterophil antibodies that react with the carbohydrate moieties of retrovirus envelope antigens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895657     DOI: 10.1007/bf02122677

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  14 in total

1.  Comparison of radioimmunoprecipitation assays for the detection of human anti-tumor virus antibodies.

Authors:  R Kurth; A Huesgen; F Katz; J Löwer
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

2.  Cell-mediated immune response to simian oncornavirus antigens in pregnant women.

Authors:  L Thiry; S Sprecher-Goldberger; M Bossens; F Neuray
Journal:  J Natl Cancer Inst       Date:  1978-03       Impact factor: 13.506

3.  Human humoral antibodies specific for primate C-type viral antigens.

Authors:  R Kurth; C Schmitt
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

4.  Induction of retrovirus particles in human testicular tumor (Tera-1) cell cultures: an electron microscopic study.

Authors:  D L Bronson; E E Fraley; J Fogh; S S Kalter
Journal:  J Natl Cancer Inst       Date:  1979-08       Impact factor: 13.506

5.  Heterophil human antibodies recognize oncovirus envelope antigens: epidemiological parameters and immunological specificity of the reaction.

Authors:  J Löwer; E A Davidson; N M Teich; R A Weiss; A P Joseph; R Kurth
Journal:  Virology       Date:  1981-03       Impact factor: 3.616

6.  Specificity of human antibodies to oncovirus glycoproteins: recognition of antigen by natural antibodies directed against carbohydrate structures.

Authors:  H W Snyder; E Fleissner
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

7.  Immunoglobulins in human serum reactive with murine Friend leukaemia virus.

Authors:  M Bendinelli; A Toniolo; D Matteucci; F Celeste; R Revoltella
Journal:  J Gen Virol       Date:  1980-02       Impact factor: 3.891

8.  Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus.

Authors:  M Barbacid; D Bolognesi; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  In animals infected by bovine leukemia virus (BLV) antibodies to envelope glycoprotein gp51 are directed against the carbohydrate moiety.

Authors:  D Portetelle; C Bruck; M Mammerickx; A Burny
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

10.  Specificities of human immunoglobulins reactive with antigens in preparations of several mammalian type-C viruses.

Authors:  H W Snyder; T Pincus; E Fleissner
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

View more
  1 in total

1.  Phylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome and prostate cancer.

Authors:  Jonas Blomberg; Ali Sheikholvaezin; Amal Elfaitouri; Fredrik Blomberg; Anna Sjösten; Johan Mattson Ulfstedt; Rüdiger Pipkorn; Clas Källander; Christina Ohrmalm; Göran Sperber
Journal:  Adv Virol       Date:  2011-09-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.